Betekenis van:
streptomycin

streptomycin
Zelfstandig naamwoord
    • an antibiotic produced by the actinomycete Streptomyces griseus and used to treat tuberculosis

    Hyperoniemen


    Voorbeeldzinnen

    1. Streptomycin,
    2. Streptomycin
    3. streptomycin
    4. NO ENTRY Streptomycin
    5. Streptomycin All ruminants, porcine, rabbit
    6. (5)either [a treatment with streptomycin 25mg/kg]
    7. Streptomycin All ruminants, porcine, rabbit 500 μg/kg 500 μg/kg 500 μg/kg 1000 μg/kg Muscle Fat Liver Kidney
    8. The product does not contain the adenyltransferase gene (aad) encoding resistance to streptomycin and spectinomycin, as present in the transformation vector used.
    9. Very high levels of antibiotics may be necessary for faecal samples and appropriate levels are: 10000 IU/ml penicillin, 10 mg/ml streptomycin, 0,25 mg/ml gentamycin, and 5000 IU/ml nystatin.
    10. TREATMENTSThey have been subjected to3.1. an internal and external antiparasitic treatment during the quarantine period3.2. eithera treatment with streptomycin 25mg/kg (6)or an antibiotic treatment effective against Leptospira spp (specify ….…mg/kg…..)
    11. TREATMENTSThey have been subjected to3.1. an internal and external antiparasitic treatment during the quarantine period3.2. eithera treatment with streptomycin 25mg/kg (6)or an antibiotic treatment effective against Leptospira spp (specify ….…mg/kg…..) (6)3.3. a vaccination against rabies (if requested) on … (dd/mm/aa) using vaccine …(type, producer and lot) test result … (6)
    12. BOVINE LEUKOSIS: AGID test or ELISA within two days after arrival and after at least 42 days (When required by the EU Member State of destination) (6)3. TREATMENTSThey have been subjected to3.1. an internal and external antiparasitic treatment during the quarantine period3.2. eithera treatment with streptomycin 25mg/kg (6)or an antibiotic treatment effective against Leptospira spp (specify ….…mg/kg…..)
    13. Commission Regulation (EC) No 703/2007 of 21 June 2007 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Dihydrostreptomycin and Streptomycin [2] is to be incorporated into the Agreement,
    14. 300 μg/kg 300 μg/kg 200 μg/kg Muscle Fat Liver Kidney Milk NO ENTRY Anti-infectious agents/Antibiotics Chicken 200 μg/kg 300 μg/kg 400 μg/kg Muscle Skin and fat Liver Not for use in animals from which eggs are produced for human consumption. Spiramycin 1 Porcine 250 μg/kg 2000 μg/kg 1000 μg/kg Muscle Liver Kidney NO ENTRY Streptomycin Streptomycin All ruminants, porcine, rabbit 500 μg/kg 500 μg/kg 500 μg/kg 1000 μg/kg Muscle Fat Liver Kidney For porcine species the fat MRL relates to ‘skin and fat in natural proportions’. Anti-infectious agents/Antibiotics All ruminants 200 μg/kg Milk Strychni semen NOT APPLICABLE Bovine, ovine, caprine No MRL required NOT APPLICABLE For oral use only at doses up to the equivalent of 0,1 mg strychnine/kg bw. NO ENTRY Strychnine NOT APPLICABLE Bovine No MRL required NOT APPLICABLE For oral use only at dose to 0,1 mg/kg bw. NO ENTRY Substances used in homeopathic veterinary medicines NOT APPLICABLE All food producing species No MRL required NOT APPLICABLE All substances used in homeopathic veterinary medicinal products provided that their concentration in the product does not exceed one part per ten thousand. NO ENTRY Sulfogaiacol NOT APPLICABLE All food producing species No MRL required NOT APPLICABLE NO ENTRY NO ENTRY Sulfonamides (all substances belonging to the sulfonamide group) Parent drug All food-producing species 100 μg/kg 100 μg/kg 100 μg/kg 100 μg/kg Muscle Fat Liver Kidney